
    
      This is Double-Blind, two arms, multi-center, Interventional, 8 weeks study starting with
      YY-162(Combination of Ginkgo extract and Ginseng extract)in children with ADHD. Assessment of
      efficacy and safety will be performed at the baseline, weeks 2, 4 and 8. At the first visit,
      a full psychiatric history, demographic date and physical examination will be undertaken.
      Throughout the study, the following procedures, documentations and evaluations will
      performed; K-ARS, IOWA conner's rating scale, CGI-S/I, ATA, Children's color trails test and
      stroop test, intelligence test(from KEDI-WISC)and adverse event reporting.
    
  